Cruickshanks, Nichola, Shervington, Leroy Alexander, Patel, Rahima, Munje, Chinmay, Thakkar, Dipti and Shervington, Amal A (2010) Can hsp90α-Targeted siRNA Combined With TMZ Be a Future Therapy for Glioma? Cancer Investigation, 28 (6). pp. 608-614. ISSN 0735-7907
Full text not available from this repository.
Official URL: http://dx.doi.org/10.3109/07357901003630967
Hsp90α's vital role in cell cycle progression and apoptosis together with its presence in gliomas and absence in normal tissue, make it a credible target for cancer therapy. Three sets of dsRNA oligos designed to align different regions of the hsp90α sequence were used to downregulate hsp90α. SiRNA 1, 2, and 3 resulted in significant levels of silencing of hsp90α after 48 hr treatment (p < .0001). Concurrent treatment of the glioma cell line U87-MG with siRNA 1 and temozolomide (TMZ) resulted in a 13-fold reduction in the dose of TMZ required to achieve a similar effect if TMZ was used alone.
|Uncontrolled Keywords (separate with ;):||Glioma; Normal brain; Hsp90α; siRNA|
|Subjects:||Subjects allied to medicine > Pharmacy|
|Schools:||College of Clinical & Biomedical Sciences > School of Pharmacy and Biomedical Sciences|
|Deposited By:||Jeannine Sullivan|
|Deposited On:||29 Mar 2012 19:28|
|Last Modified:||09 Aug 2016 15:15|
Downloads per month over past year
Downloads for past 30 days
Repository Staff Only: item control page